Create Free Account

By creating account you will get access to hot stocks & personalised emails

LBT Innovations Ltd

Healthcare AU LBT

0.017AUD
0.001(6.25%)

Last update at 2024-05-20T02:00:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.0040.04
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -20.88300M -8.75900M -9.50400M -7.41500M -5.99400M
Minority interest - - - - -
Net income -22.52400M -6.64100M -7.26000M -5.63600M -4.35000M
Selling general administrative 4.47M 5.19M 4.67M 4.12M 2.12M
Selling and marketing expenses 0.09M 0.28M - - 0.10M
Gross profit 1.71M 1.33M 1.12M 1.16M 2.33M
Reconciled depreciation 3.30M 2.93M 2.40M 2.43M 2.15M
Ebit -7.00500M -8.65500M -9.38800M -7.30300M -5.97500M
Ebitda -3.70900M -5.72400M -6.98900M -4.87200M -3.82200M
Depreciation and amortization 3.30M 2.93M 2.40M 2.43M 2.15M
Non operating income net other - - - - -
Operating income -7.00500M -8.65500M -9.38800M -7.30300M -5.97500M
Other operating expenses 9.17M 10.03M 7.78M 7.29M 6.46M
Interest expense 0.47M 0.10M 0.12M 0.11M 0.02M
Tax provision 1.64M -2.11800M -2.24400M -1.77900M -1.64400M
Interest income 0.47M 1.63M 3.83M 1.76M 2.30M
Net interest income -0.45300M -0.10400M -0.04000M -0.11200M 0.12M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 1.64M -2.11800M -2.24400M -1.77900M -1.64400M
Total revenue 2.13M 2.13M 1.12M 1.16M 2.55M
Total operating expenses 8.74M 9.23M 7.78M 7.29M 6.24M
Cost of revenue 0.43M 0.80M - 0.00000M 0.22M
Total other income expense net -13.28900M -0.10400M -0.11600M -0.11200M -0.01900M
Discontinued operations - - - - -
Net income from continuing ops -22.52400M -6.64100M -7.26000M -5.63600M -4.35000M
Net income applicable to common shares -22.52400M -6.64100M -7.26000M -5.63600M -4.35000M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 7.37M 31.52M 35.69M 33.77M 38.12M
Intangible assets 0.00000M 16.15M 14.82M 16.56M 18.12M
Earning assets - - - - -
Other current assets 0.85M 1.21M 0.87M 0.73M 1.01M
Total liab 7.47M 10.19M 10.81M 9.65M 8.61M
Total stockholder equity -0.10500M 21.34M 24.88M 24.11M 29.52M
Deferred long term liab - 16.15M 14.82M 16.56M 18.12M
Other current liab 2.02M 0.85M 0.00600M 0.03M -
Common stock 47.02M 46.27M 43.54M 35.55M 35.56M
Capital stock 47.02M 46.27M 43.54M 35.55M 35.56M
Retained earnings -49.06900M -26.58700M -19.96100M -12.71300M -7.13400M
Other liab 1.09M 4.20M 4.50M 5.08M 5.41M
Good will - - - - -
Other assets 0.86M 22.63M 22.04M 25.76M 26.55M
Cash 2.02M 2.79M 9.62M 7.10M 10.18M
Cash and equivalents 0.16M 2.79M 8.78M 6.62M 9.42M
Total current liabilities 4.19M 2.86M 2.58M 1.64M 0.97M
Current deferred revenue 0.29M 0.03M 0.04M -0.02600M -
Net debt 1.37M 1.50M -4.75700M -3.19700M -7.67500M
Short term debt 1.19M 1.16M 1.13M 0.96M 0.27M
Short long term debt 0.99M 0.96M 0.95M 0.95M 0.27M
Short long term debt total 3.39M 4.29M 4.86M 3.90M 2.50M
Other stockholder equity -1.82600M -1.93200M -2.21100M -1.71500M -1.87500M
Property plant equipment 1.67M 1.92M 2.08M 0.07M 0.09M
Total current assets 4.84M 6.98M 11.57M 7.93M 11.49M
Long term investments - - 4.69M 7.29M 7.12M
Net tangible assets -0.10500M 21.34M 24.88M 24.11M 29.52M
Short term investments - - - - -
Net receivables 0.48M 2.00M 1.08M 0.11M 0.30M
Long term debt 0.76M 1.50M 1.99M 2.97M 2.26M
Inventory 1.49M 0.98M - - -
Accounts payable 0.68M 0.82M 1.41M 0.68M 0.70M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 1.95M 1.65M 1.30M 1.28M 1.09M
Additional paid in capital - - - - -
Common stock total equity - - - 35.55M 35.56M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - 0.37M 0.35M
Deferred long term asset charges - - - - -
Non current assets total 2.53M 24.55M 24.12M 25.83M 26.64M
Capital lease obligations 1.64M 1.82M 1.92M 0.01M -
Long term debt total 2.19M 3.13M 3.73M 2.97M 2.26M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments -0.30500M -1.24100M -1.74200M -2.46100M -3.74900M
Change to liabilities 2.52M -1.60600M -0.57600M -0.98300M -1.63500M
Total cashflows from investing activities -0.30500M -1.24100M -1.74200M -2.46100M -3.74900M
Net borrowings -0.90000M -0.63700M -0.97900M 1.29M 2.50M
Total cash from financing activities 0.94M -0.63700M 6.93M 1.24M 7.16M
Change to operating activities 0.00300M 0.07M 0.14M 0.05M 0.25M
Net income -22.52400M -6.64100M -7.26000M -5.63600M -4.35000M
Change in cash -0.76800M -6.82700M 2.52M -3.07900M 2.60M
Begin period cash flow 2.79M 9.62M 7.10M 10.18M 7.57M
End period cash flow 2.02M 2.79M 9.62M 7.10M 10.18M
Total cash from operating activities -1.39800M -3.71000M -2.67300M -1.85500M -0.80700M
Issuance of capital stock 2.00M - 8.47M 0.01M 4.99M
Depreciation 0.25M 2.93M 2.40M 2.43M 2.15M
Other cashflows from investing activities 0.00000M -0.32500M -1.10800M -1.69000M -1.47600M
Dividends paid - - - 0.14M -
Change to inventory -0.51300M 0.30M 0.30M 0.30M 0.30M
Change to account receivables 1.52M -1.43200M -0.96700M 0.19M -0.05100M
Sale purchase of stock -0.16700M 0.00000M -0.55500M -0.06200M -0.33100M
Other cashflows from financing activities -0.17900M -0.16400M -0.05400M 1.50M 2.50M
Change to netincome 13.94M 1.76M 3.74M 1.80M 2.17M
Capital expenditures 0.30M 0.66M 0.67M 0.77M 2.27M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 1.45M 1.68M 2.24M 2.70M 4.35M
Stock based compensation - - - - -
Other non cash items - 3.71M 4.86M 3.21M 2.20M
Free cash flow -0.30500M -4.36500M -0.67200M -0.77100M -2.27300M

Fundamentals

  • Previous Close 0.02
  • Market Cap21.45M
  • Volume222722
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-6.46300M
  • Revenue TTM1.98M
  • Revenue Per Share TTM0.004
  • Gross Profit TTM 1.71M
  • Diluted EPS TTM-0.04

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
LBT
LBT Innovations Ltd		 0.001 6.25% 0.02 - - 14.16 11.01 13.30 -1.6166
COH
Cochlear Ltd		 -6.03 1.83% 324.36 62.10 46.30 9.75 11.76 9.62 36.63
PNV
Polynovo Ltd		 -0.02 0.96% 2.06 - 140.85 17.37 21.49 17.51 647.42
AVR
Anteris Technologies Ltd		 -0.26 1.33% 19.35 - - 104.23 14.98 95.15 -5.9152
EBR
Ebr Systems Inc CDR		 0.05 4.81% 1.09 - - - 5.68 - -7.482

Reports Covered

Stock Research & News

View All

Profile

LBT Innovations Limited engages in the research, development, and commercialization of technologies for the healthcare and laboratory supply markets in Australia, the United States, Sweden, the United Kingdom, and Germany. Its products portfolio comprises Automated Plate Assessment System (APAS) Independence, a platform technology that automates culture-plate screening and interpretation; APAS Analysis Modules, an intelligent image analysis software that enables the screening of microbiology culture plates; APAS antimicrobial resistance (AMR) Analysis Module that reads and interprets antimicrobial susceptibility tests (ASTs) for the detection of AMR; and APAS PharmaQC, which provides automated imaging, analysis, and interpretation of microbiology culture plates used in environmental monitoring. The company's products pipeline also includes Automated Gram Strain Assessment for the automated interpretation of gram stain image analysis; Biofilm, a device for detecting the biofilms in the presence of mammalian tissues; and WoundVue, a technology that uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds. LBT Innovations Limited was incorporated in 2004 and is headquartered in Adelaide, Australia.

LBT Innovations Ltd

16 Anster Street, Adelaide, SA, Australia, 5000

Key Executives

Name Title Year Born
Mr. Brenton John Barnes CEO, MD & Director NA
Mr. Raymond Robert Ridge B.A., BA (Acc), C.A., CA, GIA (cert) CFO & Company Sec. NA
Mr. Peter M. Bradley VP of Global Bus. Devel. NA
Mr. Pablo Cesar Solis Madrigal Director of Technology Devel. NA
Dr. Steven Giglio Scientific Director NA
Mr. Jack Brown Corp. Devel. Director NA
Mr. Raymond Robert Ridge B.A., BA (Acc), C.A., CA, GIA (cert) CFO, Company Secretary & Director NA
Mr. Jack Brown Corporate Development Director NA
Mr. Raymond Robert Ridge B.A., BA (Acc), C.A., CA, GIA (cert) CFO, Company Secretary & Director NA
Mr. Jack Brown Corporate Development Director NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).

Our Company

Useful Links

Contact Us

Market Research

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.